BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29434059)

  • 21. Progress in certification of poliomyelitis eradication and in laboratory containment of wild poliovirus.
    Wkly Epidemiol Rec; 2003 Nov; 78(48):410-4. PubMed ID: 14669456
    [No Abstract]   [Full Text] [Related]  

  • 22. Biosafety during a pandemic: shared resource laboratories rise to the challenge.
    Aspland AM; Douagi I; Filby A; Jellison ER; Martinez L; Shinko D; Smith AL; Tang VA; Thornton S
    Cytometry A; 2021 Jan; 99(1):68-80. PubMed ID: 33289290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smart Card Decontamination in a High-Containment Laboratory.
    Gabbert LR; Smith JD; Neilan JG; Ferman GS; Rasmussen MV
    Health Secur; 2018; 16(4):244-251. PubMed ID: 30096256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report of the International Conference on Risk Communication Strategies for BSL-4 laboratories, Tokyo, October 3-5, 2007.
    Dickmann P; Keith K; Comer C; Abraham G; Gopal R; Marui E
    Biosecur Bioterror; 2009 Jun; 7(2):227-33. PubMed ID: 19635008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European perspective of 2-person rule for biosafety level 4 laboratories.
    Ippolito G; Nisii C; Di Caro A; Brown D; Gopal R; Hewson R; Lloyd G; Gunther S; Eickmann M; Mirazimi A; Koivula T; Georges Courbot MC; Raoul H; Capobianchi MR
    Emerg Infect Dis; 2009 Nov; 15(11):1858. PubMed ID: 19891889
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of biosafety precautions in Khartoum state diagnostic laboratories, Sudan.
    Elduma AH
    Pan Afr Med J; 2012; 11():19. PubMed ID: 22514753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.
    Nisii C; Vincenti D; Fusco FM; Schmidt-Chanasit J; Carbonnelle C; Raoul H; Eickmann M; Hewson R; Brave A; Nuncio S; Sanchez-Seco MP; Palyi B; Kis Z; Zange S; Nitsche A; Kurth A; Strasser M; Capobianchi MR; Ozin A; Guglielmetti P; Menel-Lemos C; Jacob D; Grunow R; Ippolito G; Di Caro A
    Clin Microbiol Infect; 2017 Feb; 23(2):58-60. PubMed ID: 27404371
    [No Abstract]   [Full Text] [Related]  

  • 28. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects.
    Li L; Gu J; Shi X; Gong E; Li X; Shao H; Shi X; Jiang H; Gao X; Cheng D; Guo L; Wang H; Shi X; Wang P; Zhang Q; Shen B
    Clin Infect Dis; 2005 Sep; 41(6):815-21. PubMed ID: 16107979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.
    Janosko K; Holbrook MR; Adams R; Barr J; Bollinger L; Newton JT; Ntiforo C; Coe L; Wada J; Pusl D; Jahrling PB; Kuhn JH; Lackemeyer MG
    J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biosafety provision on handling pathogenic biological agents on the concept of biorisk assessment and management].
    Dobrokhotskiĭ ON; Kolombet LV
    Gig Sanit; 2010; (5):79-81. PubMed ID: 21344700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank.
    Ta L; Gosa L; Nathanson DA
    Methods Mol Biol; 2019; 1897():213-225. PubMed ID: 30539447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Novel Positive Pressure Protective Suit for a Biosafety Level 4 Laboratory in Japan.
    Shichinohe S; Sakurai Y; Hayasaka D; Yamada E; Shinohara K; Kurosaki Y; Nakajima K
    Jpn J Infect Dis; 2023 Mar; 76(2):162-166. PubMed ID: 36575023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-Based Reboot: New WHO Guidance for Laboratory Biosafety.
    Albtoush N; Noguez JH
    Clin Chem; 2018 Oct; 64(10):1544-1545. PubMed ID: 32100859
    [No Abstract]   [Full Text] [Related]  

  • 34. Biosafety principles and practices for the veterinary diagnostic laboratory.
    Kozlovac J; Schmitt B
    Methods Mol Biol; 2015; 1247():31-41. PubMed ID: 25399086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory.
    Pentella MA
    Clin Lab Med; 2020 Dec; 40(4):473-482. PubMed ID: 33121616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WHO Laboratory Biosafety Manual: A New Approach to Security.
    Ficociello B; Giordano D; Incoronato F; Farinella A; Pietrangeli B
    Ann Work Expo Health; 2023 Apr; 67(4):425-429. PubMed ID: 36495279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biosafety and biosecurity in the medical laboratory. Update and trends].
    Ionescu G; Neguţ M; Combiescu AA
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):91-9. PubMed ID: 19326721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of biosafety measures in clinical laboratories of Al-Madinah city, Saudi Arabia.
    Khabour OF; Al Ali KH; Aljuhani JN; Alrashedi MA; Alharbe FH; Sanyowr A
    J Infect Dev Ctries; 2018 Sep; 12(9):755-761. PubMed ID: 31999634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status and way forward for National Accreditation Board for Testing and Calibration Laboratories Accreditation of Laboratories in Government Organizations.
    Sinha M; Saini S; Gupta P; Gulati NS; Das A; Kumar A; Mehndiratta MM; Shekhar C
    Indian J Pathol Microbiol; 2018; 61(3):461-463. PubMed ID: 30004086
    [No Abstract]   [Full Text] [Related]  

  • 40. Biosafety considerations in handling medically important fungi.
    Padhye AA; Bennett JE; McGinnis MR; Sigler L; Fliss A; Salkin IF
    Med Mycol; 1998; 36 Suppl 1():258-65. PubMed ID: 9988515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.